Statistics about Health, Pharma & Medtech in United States
Statistics
- Opgen revenue 2019-2023
- Rhythm Pharmaceuticals liabilities 2019-2023
- Astria Therapeutics, Inc. operating profit 2019-2023
- Athenex, Inc. total equity 2018-2022
- Atara Biotherapeutics total equity 2019-2023
- Astria Therapeutics, Inc. net income 2019-2023
- Reviva Pharmaceuticals Holdings, Inc. total assets 2019-2023
- Atara Biotherapeutics liabilities 2019-2023
- Atara Biotherapeutics net cash 2019-2023
- Atara Biotherapeutics operating profit 2019-2023
- Upexi, Inc. operating profit 2020-2023
- Atara Biotherapeutics net income 2019-2023
- Atara Biotherapeutics total assets 2019-2023
- Atara Biotherapeutics revenue 2022-2023
- Oragenics Inc gross profit 2013-2017
- Rhythm Pharmaceuticals net cash 2019-2023
- United Therapeutics operating profit 2019-2023
- Athenex, Inc. net cash 2016-2020
- Otonomy revenue 2017-2021
- United Therapeutics total assets 2019-2023
- Athenex, Inc. total assets 2018-2022
- Recursion Pharmaceuticals net cash 2019-2023
- Athenex, Inc. gross profit 2018-2022
- Athenex, Inc. liabilities 2018-2022
- United Therapeutics liabilities 2019-2023
- Oramed Pharmaceuticals revenue 2019-2023
- Athenex, Inc. operating profit 2018-2022
- Reviva Pharmaceuticals Holdings, Inc. net cash 2019-2023
- Upexi, Inc. net cash 2020-2023
- Athenex, Inc. net income 2018-2022
- Athenex, Inc. revenue 2018-2022
- United Therapeutics net cash 2019-2023
- Upexi, Inc. total assets 2020-2023
- Opko Health revenue 2019-2023
- Dynavax Technologies revenue 2019-2023
- Dynavax Technologies net cash 2019-2023
- Ayala Pharmaceuticals liabilities 2017-2021
- Renovacor, Inc. operating profit 2019-2021
- Bright Green net cash 2021-2023
- Bright Green total assets 2021-2023
- Bright Green total equity 2020-2023
- Ngm Biopharmaceuticals Inc total assets 2019-2023
- Tango Therapeutics, Inc. total equity 2019-2023
- Tenaya Therapeutics total equity 2019-2023
- Zoetis revenue 2019-2023
- Zoetis liabilities 2019-2023
- Omeros total assets 2019-2023
- Replimune Group operating profit 2019-2023
- Tempest Therapeutics, Inc. net cash 2019-2023
- Oragenics Inc total assets 2019-2023
- Tyme Technologies, Inc. liabilities 2017-2021
- Rebus Holdings operating profit 2018-2022
- Therapeuticsmd liabilities 2019-2023
- Bright Green liabilities 2021-2023
- Trevena net cash 2019-2023
- Rani Therapeutics Holdings operating profit 2020-2023
- Otonomy net cash 2017-2021
- Taysha Gene Therapies net cash 2020-2023
- Therapeuticsmd net cash 2017-2021
- Tyme Technologies, Inc. net cash 2017-2021
- Tempest Therapeutics, Inc. total assets 2019-2023
- Oramed Pharmaceuticals net cash 2019-2023
- Dyadic International total assets 2019-2023
- Dyadic International net cash 2019-2023
- Dyadic International operating profit 2019-2023
- Trevena total assets 2019-2023
- Dyadic International total equity 2019-2023
- Dyadic International liabilities 2020-2023
- Bright Green operating profit 2021-2023
- Benitec Biopharma Inc. net cash 2020-2024
- Disc Medicine, Inc. net cash 2020-2023
- Twinlab Consolidated Holdings total equity 2019-2023
- Elutia net cash 2019-2023
- Elutia gross profit 2019-2023
- Elutia total equity 2019-2023
- Elutia liabilities 2019-2023
- Elutia revenue 2019-2023
- Elutia net income 2019-2023
- Replimune Group liabilities 2019-2023
- Nutra Pharma Corp net cash 2017-2021
- Thorne Healthtech total equity 2021-2022
- Oramed Pharmaceuticals total assets 2019-2023
- Renovacor, Inc. liabilities 2019-2021
- Theseus Pharmaceuticals, Inc. total equity 2019-2022
- Nrx Pharmaceuticals net cash 2019-2023
- Opgen total assets 2019-2023
- Opko Health total assets 2019-2023
- Benitec Biopharma Inc. total assets 2020-2023
- Rebus Holdings liabilities 2018-2022
- Organovo Holdings total assets 2019-2023
- Benitec Biopharma Inc. liabilities 2020-2023
- Oncosec Medical total assets 2018-2022
- Atreca, Inc. total equity 2018-2022
- Neximmune total assets 2020-2023
- Trex Wind-Down, Inc. total equity 2018-2022
- Rani Therapeutics Holdings liabilities 2020-2023
- Atreca, Inc. liabilities 2018-2022
- Benitec Biopharma Inc. revenue 2020-2024
- Atreca, Inc. total assets 2018-2022
- Benitec Biopharma Inc. total equity 2019-2023